Platelet function testing in uraemic patients

References

• Morgagni GB. Opera Omnia, in quinque tomos divisa, quorum operum qu antea,et ubi, et qu nun sint edita, prfatio ostendent. Venice: Veretiis ex typographia Remondiniae, 1764.
   Google Scholar
• Bright R. Tabular view of the morbid appearance in 100 cases connected with albuminous urine: with observations. Guy's Hosp Rep 1836; 1: 380–400.
   Google Scholar
• Weigert AL, Schafer Al. Uremic Bleeding: Pathogenesis and Therapy. Am J Med Sc 1998; 316(2): 94–104.
   PubMed Web of Science ®Google Scholar
• Rao AK. Acquired disorders of platelet function. In: Michelson AD (ed). Platelets. Amsterdam: Elsevier Science, 2002; 701–727.
   Google Scholar
• Remuzzi G. Bleeding in renal failure (review) Lancet 1988; 1: 1205–1208
   Google Scholar
• Noris M, Remuzzi G. Uremic bleeding: Closing the circle after 30 years of Controversies? Blood 1999; 94(8): 2569–2574.
   PubMed Web of Science ®Google Scholar
• Rabiner SF, Molinas F. The role of phenol and phenolic acids onthe thrombocytopathy and defective platelet aggregation of patients with renal failure. Am J Med 1970; 49: 346–351.
   PubMed Web of Science ®Google Scholar
• Horowitz HI, Stein IM, Cohen BD, White JG. Further studies onthe platelet inhibitory effect of guanidine succinic acid and its role in uremic bleeding. Am J Med 1970; 49: 336–345.
   PubMed Web of Science ®Google Scholar
• Castaldi PA, Rozenberg MC, Stewart JH. The bleeding disorder of uraemia. A qualitative platelet defect. Lancet 1966;66.
   Google Scholar
• Eknoyan G, Wacksman Si, Glueck H, Will H. Platelet function in renal failure. N Engl J Med 1969; 280(13): 677–681.
   PubMed Web of Science ®Google Scholar
• Harker LA, Slichter SI. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972; 287(4): 155–159.
   PubMed Web of Science ®Google Scholar
• Steiner RW, Coggins C, Carvalho A. Bleeding time in uraemia: a useful test to assess clinical bleeding. Am J Hemato1, 1979; 7: 107–117.
   PubMed Web of Science ®Google Scholar
• Mannucci PM, Remuzzi G, Pusineri F, Zimmerman TS, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uraemia. N Engl J Med 1983; 308(1): 8–12.
   PubMed Web of Science ®Google Scholar
• Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. J Am Soc Hematol 1997; 90(7): 2515–2521.
   Google Scholar
• Livio M, Remuzzi G, Marchesi D, Gaetano G, et al. Uraemic bleeding: Role of anaemia and beneficial effect of red cell transfusions. Lancet 1982; 2:1013–1015.
   PubMed Web of Science ®Google Scholar
• Holloway DS, Vagher JP, Caprini JA, et al. Thromboelastography of blood from subjects with chronic renal failure. Thromb Res 1987; 45(6): 817–25
   PubMed Web of Science ®Google Scholar
• Gawaz MP, Dobos G, Spath M, et al. Impaired function of plateletmembrane glycoprotein IIb-IIIa in end-stage renal disease. J Am Soc Nephrol 1994;5:36–46
   PubMed Web of Science ®Google Scholar
• Orsende JI, Fuster V, Eli I, Varon D, Badimon ii, et al. Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests. Relevance for monitoring long-term Glycoprotein IIb/IIIa inhibition. Circulation 2001; 103: 1488–1491.
   PubMed Web of Science ®Google Scholar
• Mielke CH. Measurement of the bleeding time. International Committee Communications. Thromb Haemost 1984; 52(2): 210–211.
   PubMedGoogle Scholar
• Refaai MA, Laposta M. Platelet aggregation. In: Michelson AD (ed.). Platelets. San Diego: Academic Press; 2004; 291–296.
   Google Scholar
• Kenet G, Lubetsky A, Shenkman B, Varon D, et al. Cone and plateletanalyzer (CPA): a new test for the prediction of bleeding among thrombocytopenic patients. Br J Haematol 1998; 101: 255–259.
   PubMed Web of Science ®Google Scholar
• Rodgers RPC, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990; 16: 1–20.
   PubMed Web of Science ®Google Scholar
• Lind SE. The bleeding time does not predict surgical bleeding. Blood 1991; 77: 2547–2552.
   PubMed Web of Science ®Google Scholar
• Mattix H, Singh AK. Is the bleeding time predictive of bleeding prior to a percutaneous renal biopsy? Curr Opin Nephrol Hypertens 1999; 8: 715–718.
   PubMed Web of Science ®Google Scholar
• Lehman CM, Blaylock RC, Alexander DP, Rodgers GM. Discontinuation of the bleeding time test without detectable adverse clinical impact. Clin Chem 2001; 47(7): 1204–1211.
   PubMed Web of Science ®Google Scholar
• O'Laughlin JC, Hoftiezer JW, Mahoney JP, Ivey KJ. Does aspirin prolong bleeding from gastric biopsies in man? Gastrointest Endosc 1981; 27: 1–5.
   PubMed Web of Science ®Google Scholar
• MacDonald JD, Remington BJ, Rodgers GM. The skin bleeding time test as a predictor of brain bleeding time in a rat model. Throm Res 1994; 76: 535–540.
   PubMed Web of Science ®Google Scholar
• Royal College of Pathologists of Australia (RCPA) manual, 4th Edition. www.rcpamanual.edu.au.
   Google Scholar
• Mammen EF, Comp PC, Gosselin R, et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998; 24: 195–202.
   PubMed Web of Science ®Google Scholar
• Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001; 138: 152–163.
   PubMed Web of Science ®Google Scholar
• Favaloro EJ. Utility of the PFA-100R for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations. Haemophilia 2001; 7: 170–179.
   PubMed Web of Science ®Google Scholar
• Haubelt H, Anders C, Vogt A et al. Variables influencing Platelet Function Analyzer-100Tm closure times in healthy individuals. Br J Haematol 2005; 130: 759–767.
   PubMed Web of Science ®Google Scholar
• Francis JL. Platelet function analyzer (PFA-100). In: Michel-son AD, (ed). Platelets. San Diego: Academic Press, 2004; 325–335.
   Google Scholar
• Escolar G, Cases A., Vinas M et al. Evaluation of acquired plateletdysfunction in uremic and cirrhotic patients using the platelet function analyzer (PFA-100): influence of hematocrit elevation. Haematologica 1999; 84: 614–619.
   PubMed Web of Science ®Google Scholar
• Zupan IP, Sabovic M, Ponikvar J, et al. Utility of in vitro closure time test for evaluation platelet-related primary hemostasis in dialysis patients. Am J Kidney Dis 2003; 42(4): 746–751.
   PubMed Web of Science ®Google Scholar
• Harrison P. The role of PFA-100® testing in the investigation and management of haemostatic defects in children and adults. Br J Haematol 2005; 130: 3–10.
   PubMed Web of Science ®Google Scholar
• Hayward CPM, Harrison P, Cattaneo M, et al. Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4: 312–319.
   PubMed Web of Science ®Google Scholar
• Harrison P. Measuring platelet function? Hematol J 2004; 5,5164—S169.
   Google Scholar
• Harrison P. Progress in the assessment of platelet function. Br J Haematol 2000; 111: 733–744.
   PubMed Web of Science ®Google Scholar
• Varon D, Savion N. Cone and platelet analyzer. In: Michelson AD (ed). Platelets. Amsterdam: Elsevier Science, 2002; Ch. 23
   Google Scholar
• Varon D, Dardi R, Tamarin I, Savion N, et al. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997; 85(4): 283–294.
   PubMed Web of Science ®Google Scholar
• Peerschke E, Silver RS, Weksler B, Varon D, et al. Ex vivo evaluation of erythrocytosis-enhanced platelet thrombus formation using the cone and platelet analyzer:effect of platelet antagonists. Br J Haematol 2004; 127: 195–203.
   PubMed Web of Science ®Google Scholar
• Pivalizza EG, Abramson DC, Harvey A. Perioperative hypercoa-gulability in uremic patients: a viscoelastic study. J Clin Anesth 1997; 9(6): 442–445.
   PubMed Web of Science ®Google Scholar